NEW YORK (GenomeWeb) – Trovagene today announced a collaboration with City of Hope to explore the clinical utility of the company's Precision Cancer Monitoring platform for detecting and monitoring EGFR mutations in lung cancer patients.
NEW YORK (GenomeWeb) – Trovagene today announced a collaboration with City of Hope to explore the clinical utility of the company's Precision Cancer Monitoring platform for detecting and monitoring EGFR mutations in lung cancer patients.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.